Biliary Catheters - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The biliary catheters market size is expected to grow from USD 3.01 billion in 2025 to USD 3.23 billion in 2026 and is forecast to reach USD 4.59 billion by 2031 at 7.28% CAGR over 2026-2031. This report is Segmented by Product Type (Single, Double, Multi-Lumen), Material (Polyurethane, PVC, Silicone), Procedure (Diagnostic, Therapeutic), Functionality (Drainage, Stent Placement, Stone Removal), Application (Cholangiography, Hepatobiliary & GI, Oncology), End User (Hospitals, Ascs, Clinics), and Geography (North America, Europe, Asia-Pacific, MEA, South America). Forecasts are in Value (USD).

Global Biliary Catheters Market Trends and Insights

Rising ERCP and PTBD Procedure Volumes

Rising ERCP and PTBD procedure volumes remain the clearest demand base for the biliary catheters market, as most obstruction pathways continue to rely on these two interventions across routine and complex care settings. ERCP supports stent placement, stone extraction, stricture dilation, and nasobiliary drainage, while PTBD adds demand when endoscopic access fails or hilar anatomy favors percutaneous drainage. MedPAC reported a 5.7% increase in ASC surgical procedures per FFS Medicare beneficiary in 2024, showing that GI and related interventions continue to shift to lower-cost outpatient settings. As volumes expand across hospitals, day-care centers, and specialized outpatient facilities, the market benefits from a broader installed base that favors ready-to-use, workflow-friendly, and increasingly disposable catheter formats.

Rising Need for Minimally Invasive Biliary Decompression

The shift toward minimally invasive decompression is expanding the clinical relevance of the biliary catheters market, as surgery is no longer the preferred first-line option for many biliary obstruction cases. Endoscopic and percutaneous approaches reduce patient burden, shorten recovery, and align with care pathways that prioritize faster stabilization and fewer inpatient days. EUS-guided biliary drainage is also strengthening demand for slimmer delivery systems and specialized access tools. A 2025 Endoscopy paper described hepaticogastrostomy using a catheter-like delivery system that omitted the fistula dilation step, highlighting the business value of simpler access designs that shorten workflows and reduce exchange steps.

Reprocessing and Infection-Control Burden for Reusable Ancillary Equipment

Infection-control requirements continue to restrain the biliary catheters market, as reusable ancillary equipment increases costs, documentation needs, and operational pressure for endoscopy programs. Infection events linked to duodenoscope use have led hospitals and regulators to strengthen reprocessing standards and oversight of contaminated-device risk. Boston Scientific noted the broader impact of these changes in its 2025 Form 10-K, linking demand for single-use platforms and related accessories to hospital efforts to manage contamination risk and improve workflow control.

In the near term, higher compliance spending may delay upgrades to premium catheter systems, especially in facilities with moderate procedure volumes compared to large tertiary centers. Smaller hospitals and emerging-market providers face greater pressure because they have less capacity to absorb sterilization burdens and device premium costs at the same time. As a result, the market benefits from the long-term shift toward disposables but continues to face short-term budget constraints as providers balance infection-control needs with procedure budgets.

Other drivers and restraints analyzed in the detailed report include:

• Wider Adoption of Hydrophilic and Radiopaque Catheter Designs
• Higher Biliary Cancer and Stricture Workup Rates
• Procedure-Specific Reimbursement Pressure in Cost-Managed Settings

Segment Analysis

Double lumen biliary catheters accounted for 42.65% of the biliary catheters market share in 2025, maintaining the leading product position as they support drainage and contrast delivery in a single device session. Their adoption remains strong in hospital ERCP suites, where physicians often move from visualization to therapy without a device change. Hospitals continue to prefer these products because they reduce exchanges, save time, and support predictable workflows in high-acuity settings.

Single lumen biliary catheters are projected to grow at a CAGR of 8.93% through 2031, supported by simpler diagnostic use, lower-cost configurations, and alignment with outpatient standardization goals. Their growth also reflects the shift toward single-use accessory ecosystems that reduce contamination risks and simplify inventory planning. Olympus Medical Systems received FDA 510 (k) clearance in May 2025 for the Single Use Cannula V, K250573, supporting the broader move toward single-use ERCP accessory sets in regulated markets. Multi-lumen biliary catheters remain specialized for complex hilar obstruction cases that require multi-drain planning and command higher average selling prices.

Polyurethane acccounted 43.45% of the 2025 material segment, keeping it central to the biliary catheters market because it balances flexibility, kink resistance, and handling control in difficult anatomy. Hospitals rely on polyurethane for cases that require dimensional stability during guidewire support, fluoroscopic navigation, and manipulation through tortuous biliary pathways. Its clinical familiarity supports purchasing preference in tertiary care environments where reliability is a key procurement factor.

Polyvinyl chloride is the fastest-growing material segment, with a projected CAGR of 9.67% through 2031, supported by lower cost and suitability for disposable device formats preferred by outpatient centers. The biliary catheters industry continues to monitor formulation changes, as DEHP-related concerns and regulatory scrutiny could affect PVC’s compliance and cost position. Surface engineering may narrow material performance differences, while silicone continues to serve a smaller niche in longer-dwell percutaneous drainage where sustained biocompatibility is important.

Complete Report Scope:

• By Product Type
  • Single Lumen Biliary Catheters
  • Double Lumen Biliary Catheters
  • Multi-Lumen Biliary Catheters
• By Material
  • Polyurethane
  • Polyvinyl Chloride
  • Silicone
• By Procedure
  • Diagnostic
  • Therapeutic
• By Functionality
  • Drainage
  • Stent Placement
  • Stone Removal
• By Application
  • Cholangiography Procedures
  • Hepatobiliary and Gastroenterology
  • Oncology
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 41.88% of the biliary catheters market share in 2025, maintaining its position as the largest regional contributor. Mature reimbursement structures, strong procedural infrastructure, and a broad installed base support faster adoption of single-use and premium accessory formats. Infection-control policies continue to drive recurring demand as disposable scopes and accessories gain adoption. Boston Scientific reported USD 2.916 billion in Endoscopy segment net sales in 2025, with 7.7% organic growth, supported by its WallFlex Biliary RX Stent Systems, SpyGlass DS II platform, and EXALT Model D single-use duodenoscope.

Europe remains the second-largest geography in the biliary catheters market, with Germany, France, the United Kingdom, and Italy serving as major procedural anchors. Tighter regulatory oversight and clinical evidence requirements favor manufacturers with strong post-market surveillance and documentation capabilities. The expansion of interventional endoscopy across Southern and Central Europe is also broadening the addressable procedural base. Medi-Globe GmbH received FDA 510 (k) clearance in April 2026 for the Endoflux Biliary & Pancreatic Stent Sets, K251658, after a 321-day extended review, highlighting its focus on regulated market expansion.

Asia-Pacific is the fastest-growing region in the biliary catheters market, with a projected CAGR of 8.56% through 2031, supported by rising age-related stone burden, higher oncology-linked biliary demand, and expanding interventional capacity. The 2024 Chinese Medical Journal study showed continued long-term growth in biliary tract cancer burden, supporting sustained procedural demand. China and India remain key growth engines as infrastructure investment expands access to advanced biliary interventions, while South Korea is gaining visibility through FDA 510 (k) clearances for Taewoong Medical’s Niti-S Biliary Stent, K251123, in December 2025 and S&G Biotech’s EGIS Biliary Double Bare Stent, K242845, in 2025. The Middle East and Africa and South America remain smaller but emerging parts of the market, supported by infrastructure expansion and private healthcare investment despite current constraints in specialist access and fluoroscopy-equipped facilities.

List of Companies Covered in this Report:

• Abbott Laboratories
• AngioDynamics
• Argon Medical Devices
• B. Braun
• Beckton Dickinson
• Beijing Lepu Medical Technology Co., Ltd.
• Boston Scientific
• Cardinal Health
• Conmed
• Cook Group
• Endo-Flex
• Hanmi Medical Co., Ltd.
• JW Medical Corporation
• Medtronic
• Merit Medical Systems
• Micro-tech
• Olympus
• Rontis Medical S.A.
• SMT Medical GmbH
• Teleflex

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support